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Introduction
Prasugrel is a thienopyridine anti-platelet agent used for
managing cardiac patients under going percutaneous
coronary intervention (PCI) or stent placement to
reduce thrombotic event rate. Prasugrel has multiple
side effects, however, only one case of an allergic reac-
tion has been reported to the drug before.
Methods
A 54 year old male with past medical history of diabetes,
hypertension and hyperlipidemia presented with angina.
The cardiac catheterization showed significant coronary
artery disease with left anterior descending artery block-
age. During the process of placing 4 drug eluting stents
into the artery a loading dose of Prasugrel 60 mg was
administered and subsequently a Prasugrel 10 mg dose
was given on daily basis until day 7. Per the patient he
started having some itching on the back of his neck and
face immediately after taking the loading dose of Prasu-
grel. Patient continued the Prasugrel for 7 more days
before he developed a pruritic maculopapular rash starting
on his extremities and then spreading to the trunk and
back. Patient sought an allergist consult immediately after
the development of this rash. The allergist’s assessment
was that this was a drug eruption of morbilliform nature.
Patient was started on a oral steroid - Prednisone 40 mg
PO daily tapering to 10 mg over 7 days with antihista-
mines (diphenhydramine 50 mg at night + cetirizine 10 g
in the morning). Prasugrel was discontinued and the
patient was started on clopidogrel 10 mg as an alternative
for antithrombotic prophylaxis. Patient’s rash slowly
dissipated over one week. The patient has not developed
the rash again on the alternative regimen of clopidogrel.
Conclusion
Exanthematous drug eruptions may occur in up to 1-5 %
of first time users of most drugs. The drug eruption typi-
cally appears 4-21 days after the person starts taking the
causative agent. The eruption is usually characterized by
symmetrically distributed macules and papules that may
coalesce. Prompt recognition to the signs and symptoms
of a cutaneous reaction secondary to a drug should alert
the clinician to act by stopping the causative drug and
using acceptable alternatives.
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